Upgrade

Finvezto Toolkit

Natco Pharma's Q2 consolidated profit fell 61% to Rs 203 crore as revenue dropped about 29%.

Results · 13 Nov 2026 · Natco Pharma (NATCOPHARM)

results
Latest quarter₹ Cr
Operating profit258
Net profit203

Lower sales of generic Lenalidomide, a cancer drug, drove the fall, and EBITDA dropped 55% to Rs 258 crore.

Company page · Results tracker

Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.